A huge community of microorganisms lives on and in our body – the microbiota. It is often also referred to as the microbiome, although the term microbiome actually describes the genetic information of the microbiota....
Pathogenic bacteria are armed with a large arsenal of molecular weapons that help them infect their hosts. These virulence factors enable the bacteria to gain access to nutrients, to establish a niche for survival or...
Currently, high numbers of infections with the coronavirus SARS-CoV-2 are being recorded in many European countries. This leads to increased numbers of deaths and is a burden for society, health systems and the economy....
SARS-CoV-2 infections pose a global threat to human health and a formidable research challenge. One of the most urgent tasks is to gain a detailed understanding of the molecular interactions between the virus and the...
Prof Rolf Müller, Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), has been awarded the Gottfried Wilhelm Leibniz Prize 2021 by the German Research Foundation (DFG) for his...
Hospital-acquired bacterial pneumonia is the most frequent nosocomial infection. It is mostly caused by the bacterium Staphylococcus aureus, which in many cases is already resistant to commonly used antibiotics and is...
Der Haushaltsausschuss des Bundes hat dem Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) Förderung in Höhe von 47 Millionen Euro für den weiteren Ausbau des Instituts zugesichert. Zusammen mit Mitteln...
The annual list of “Highly-cited researchers” identifies scientists who have demonstrated a significant impact in their chosen field over the last ten years through the publication of several highly-cited papers. This...
